Why do children require a Hemoccult (fecal occult blood test) when starting medications for infantile spasms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Children require a Hemoccult test when starting medications for infantile spasms because certain treatments can cause gastrointestinal irritation and bleeding, and early detection is crucial to prevent morbidity and mortality. When initiating medications like adrenocorticotropic hormone (ACTH) and oral steroids, such as prednisolone, for infantile spasms, healthcare providers must consider the potential risks of gastrointestinal side effects, including bleeding and ulceration 1. The medical evaluation before starting pharmacotherapy, as outlined in the practice parameter on the use of psychotropic medication in children and adolescents, emphasizes the importance of assessing the child's medical history and considering targeted medical testing to establish a baseline before initiating medications with known risks 1. Key points to consider in this context include:

  • The potential for gastrointestinal irritation and bleeding with certain medications, such as ACTH and oral steroids
  • The importance of early detection of occult blood in the stool to prevent severe complications
  • The use of hemoccult testing as a standard monitoring protocol when initiating powerful anti-seizure treatments
  • The possible need for gastric protection medications or dose adjustments if gastrointestinal injury is detected. Given the potential risks associated with these medications, healthcare providers should prioritize hemoccult testing to ensure the safety and well-being of children starting treatment for infantile spasms, as this approach aligns with the principle of completing a medical evaluation to minimize risk before initiating pharmacotherapy 1.

From the FDA Drug Label

WARNINGS AND PRECAUTIONS ... Anemia: Monitor for symptoms of anemia ( 5.7)

The FDA drug label does not answer the question.

From the Research

Background on Infantile Spasms

  • Infantile spasms are a unique and severe form of epilepsy associated with poor neurologic and developmental outcomes 2.
  • The primary goal of treatment is rapid and complete control of spasms 2.

Treatment Options for Infantile Spasms

  • Several treatment options are available, including synthetic adrenocorticotropic hormone (ACTH), repository corticotropin injection (RCI/Acthar Gel), corticosteroids, valproic acid, vigabatrin, and surgery 3.
  • Vigabatrin is an effective treatment for infantile spasms, particularly in cases related to tuberous sclerosis 4, 5.

Hemoccult (Fecal Occult Blood Test) Requirement

  • There is no direct evidence in the provided studies to explain why children require a Hemoccult (fecal occult blood test) when starting medications for infantile spasms.
  • However, it is possible that the test is required to monitor for potential side effects of certain medications, such as gastrointestinal bleeding, although this is not explicitly stated in the provided studies.

Medication Side Effects

  • Vigabatrin is associated with a black-box warning for permanent bilateral concentric visual field defects 5.
  • Other side effects of vigabatrin include transient drowsiness and agitation 4.
  • The side effect profiles of other treatment options, such as ACTH and corticosteroids, also vary 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment modalities for infantile spasms: current considerations and evolving strategies in clinical practice.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2024

Research

[Treatment of infantile spasms with vigabatrin as first-line therapy and in monotherapy: apropos of 70 infants].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1998

Research

Vigabatrin for infantile spasms.

Pharmacotherapy, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.